Provided herein are antibodies that target tumors, wherein the binding of the antibody to the tumor is dependent on the expression of one or more glycosyltransferases in the tumor. These antibodies bind preferentially to tumor tissue as compared to normal tissue. Such antibodies are used in methods of inhibiting tumor cell growth.